The role of eosinophils in the pathobiology of Hodgkin's disease

Annals of Oncology

Volumn 8, Issue SUPPL. 2, 1997, Pages

  Pinto, A ^a,c   Aldinucci, D ^a   Gloghini, A ^a   Zagonel, V ^a   Degan, M ^a   Perin, V ^a   Todesco, M ^a   De Iuliis, A ^a   Improta, S ^a   Sacco, C ^a   Gattei, V ^a   Gruss, H J ^b   Carbone, A ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c Department of Medical Oncology   (Italy)

Author keywords

Eosinophils; Hodgkin's disease; Reed Sternberg cells; TNF like ligands

Indexed keywords

CD30 ANTIGEN; CD40 ANTIGEN; CYTOKINE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; LIGAND; MESSENGER RNA; RECEPTOR; TUMOR NECROSIS FACTOR;

CELL PROLIFERATION; CELL SEPARATION; CONFERENCE PAPER; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; EOSINOPHIL; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; REED STERNBERG CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 8544230592     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_2.S89     Document Type: Conference Paper

References (65)

1. Kaplan HS. Hodgkin's Disease, 2nd ed. Cambridge: Harvard University Press 1980.
2. Kadin ME. Pathology of Hodgkin's disease. Curr Opin Oncol 1994; 6: 456-63.
3. Gruss H-J, Hermann F, Drexler HG. Hodgkin's disease: A cytokine producing tumor. Crit Rev Oncogen 1994; 5: 23-88.
4. Haluska FG, Brufsky AM, Cannellos GP. The cellular biology of Reed-Sternberg cell. Blood 1994; 84: 1005-19.
5. Gruss H-J, Dower SK. TNF ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378-404.
6. Poppema S. The biology of Hodgkin's disease. Ann Oncol 1992; 3 (Suppl 4): S5-8.
7. Paietta E. Cell adhesion molecules in Hodgkin's disease. Ann Oncol 1992; 3 (Suppl 4): S17-9.
8. Gruss H-J, Duyster J, Herrmann F. Structural and biological features of the TNF receptor and TNF ligand superfamilies: Interactive signals in the pathobiology of Hodgkin's disease. Ann Oncol 1996; 7 (Suppl 4): 19-26.
9. Smith GA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 1994; 76: 959-62.
10. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12: 1-12.
11. Dreschfeld J. Clinical lecture on acute Hodgkin's disease. BMJ 1892; 1: 893.
12. Major RH, Leger LH. Marked eosinophilia in Hodgkin's disease. JAMA 1939; 112: 2601-3.
13. Samoszuk MK, Ramzi E. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease. Leuk Lymph 1993; 9: 315-9.
14. Fuggle WJ, Crocker J, Smith PJ. A quantitative study of eosinophil polymorphs in Hodgkin's disease. J Clin Pathol 1984; 37: 267-71.
15. Samoszuk MK, Nathwani BN, Lukes RJ. Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas. Am J Pathol 1986; 125: 426-9.
16. Samoszuk MK, Sholly S, Epstein AL. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease. Lab Invest 1987; 56: 394-7.
17. Butterfield JH, Kephart GM, Banks PM, Gleich GJ. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. Blood 1986; 68: 1250-5.
18. Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990; 75: 13-6.
19. Merz H, Fliedner A, Orscheschek K et al. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Am J Pathol 1991; 139: 1173-80.
20. Gruss H-J, Brach MA, Drexler HG et al. Expression of cytokine genes, cytokine receptors genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 1992; 52: 3353-60.
21. Klein S, Jucker M, Diehl V, Tesch H. Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol Oncol 1992; 10: 319-29.
22. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. Part 2. Continuous cell lines. Leuk Lymph 1993; 9: 1-25.
23. Enokihara H, Nagashima S, Furusawa S. Eosinophilopoietic factors. In Eosinophils. Boca Raton, FL: CRC Press 1993; 213-25.
24. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-7.
25. Sanderson CJ. Interleukin-5, eosinophils and disease. Blood 1992; 79: 3101-9.
26. Wardlaw AJ, Moqbel R, Kay AB. Eosinophils: Biology and role in disease. Adv Immunol 1995; 60: 151-266.
27. Samoszuk M. IgE in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1992; 76: 1518-22.
28. Brattig NW, Medina-De la Garza CE, Tischendorf FW. Comparative study of eosinophils purification on nycodenz, metrizamide. and percoll density gradients. Eur J Haematol 1987; 39: 148-53.
29. Hansel TT, Pound JD, Pilling D, Kitas GD et al. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 1989; 122: 97-103.
30. Gruss H-J, Boiani N, Williams DE et al. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994; 83: 2045-56.
31. Gruss H-J, Pinto A, Gloghini A et al. CD30 ligand expression in normal, reactive and Hodgkin's disease-involved lymph nodes. Am J Pathol 1996; 149: 469-81.
32. Gruss H-J, Hirschstein D, Wright B et al. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 1994; 84: 2305-14.
33. Alderson MR, Smith CA, Tough TW et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol 1994; 24: 2219-2.
34. Dürkop H, Latza U, Himmelreich P, Stein H. Expression of the human OX40 (hOX40) antigen in normal and neoplastic tissues. Br J Haematol 1995; 91: 927-31.
35. Carbone A, Gloghini A, Gattei V et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780-9.
36. Carbone A, Gloghini A, Zagonel V et al. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 1995; 86: 4617-26.
37. Manfioletti G, Gattei V, Buratti E et al. Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood 1995; 85: 1237-45.
38. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987; 162: 156-60.
39. Gruss H-J, Da Silva N, Hu Z-B et al. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines. Leukemia 1994; 8: 2083-94.
40. Gruss H-J, Ulrich D, Braddy S et al. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur J Immunol 1995; 25: 2083-9.
41. Smith CA, Gruss H-J, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349-60.
42. Yang Y-C. Human Interleukin-9: A new cytokine in hematopoiesis. Leuk Lymph 1992; 8: 441-7.
43. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol Today 1996; 17: 138-42.
44. Sanders ME, Makogba MW, Sussman EH et al. Molecular pathways of adhesion in spontaneous resetting of T-lymphocytes to the Hodgkin's cell line L428. Cancer Res 1988; 48: 37-40.
45. Delabie J, Ceuppens JL, Vandeberghe P et al. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 1993; 82: 2845-9.
46. Munro JM, Freedman AS, Aster JC et al. In vivo expression of the B7 costimulatory molecule by subsets of antigen presenting cells and the malignant cells of Hodgkin's disease. Blood 1994; 83: 793-7.
47. Mertz H, Houssiau FA, Orsheschek K et al. Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991; 78: 1311-7.
48. Gruss H-J, Scheffrahn I, Hübinger G et al. The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells. Leukemia 1996; 10: 829-35.
49. Owen WF, Rothenberg ME, Petersen J et al. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989; 170: 343-8.
50. Koike T, Enokihara H, Arimura H et al. Serum concentrations of IL-5, GM-CSF, and IL-3 and the production by lymphocytes in various eosinophilia. Am J Hematol 1995; 50: 98-102.
51. Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 73: 775-8.
52. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-4.
53. Endo M, Usuki K, Kitazume K et al. Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor. Acta Hematol 1995; 71: 313-4.
54. Gauchat JF, Henchoz S, Fattah D et al. CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995; 25: 863-5.
55. Druilhe A, Cai Z, Hailé S et al. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996; 87: 2822-30.
56. Carbone A, Gloghini A, Gruss H-J, Pinto A. CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphoma and Hodgkin's disease. Am J Pathol 1995; 147: 912-22.
57. Alzona M, Jäck H-M, Fisher R, Ellis TM. CD30 defines a subset of activated human T cells that produce IFN-y and IL-5 and exhibit enhanced B cell helper activity. J Immunol 1994; 153: 2861-7.
58. Del Prete GF, De Carli M, Almerigogna F et al. Preferential expression of CD30 by human CD4+ T-cells producing Th2-type cytokines. FASEB J 1995; 9: 81-6.
59. Del Prete GF, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines, and HIV infection: A complex and fascinating link. Immunol Today 1995; 16: 76-80.
60. Schulze-Osthoff K. The FAS/APO-1 receptor and its deadly ligand. Trends Cell Biol 1994; 4: 421-6.
61. Vaughan Hudson B, Linch DC, Macintyre EA et al. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report no. 31). J Clin Pathol 1987; 40: 247-50.
62. Desenne JJ, Acquatella G, Stern R et al. Blood eosinophilia in Hodgkin's disease. Cancer 1992; 69: 1248-53.
63. Toth J, Dworak O, Sugar J. Eosinophil predominance in Hodgkin's disease. Z Krebsforsch 1977; 89: 107-11.
64. Enblad G, Sundstrom G, Glimelius B. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 1993; 11: 187-93.
65. Falini B, Pileri S, Pizzolo G et al. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1-14.